Free Trial

UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Johnson Financial Group Inc.

UnitedHealth Group logo with Medical background

Johnson Financial Group Inc. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,700 shares of the healthcare conglomerate's stock after selling 761 shares during the period. Johnson Financial Group Inc.'s holdings in UnitedHealth Group were worth $10,144,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Norges Bank purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $6,375,744,000. Raymond James Financial Inc. acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $1,914,740,000. Amundi increased its position in shares of UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC lifted its holdings in shares of UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. Finally, Capital International Investors increased its holdings in UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on UNH. Mizuho increased their target price on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. JPMorgan Chase & Co. cut their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a report on Thursday. Finally, Truist Financial cut their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $603.05.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Performance

UNH opened at $418.20 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $382.53 billion, a price-to-earnings ratio of 26.98, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business has a 50 day moving average price of $503.28 and a two-hundred day moving average price of $535.01. UnitedHealth Group Incorporated has a 1-year low of $412.02 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.01%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines